Iatrogenic pacemaker-induced ventricular arrhythmia: a case report. Issue 5 (3rd May 2022)

• Record Type: Journal Article
• Authors: Pooranachandran, Vivetha; Hodson, Tim; Nicolson, Will; Ng, Ghulam Andre
• Editors: Niederseer, David; Barbieri, Fabian; Vandenbriele, Christophe; Liu, Zhiyu; Fawzy, Ameenathul Mazaya
• Is Part Of: European heart journal. Volume 6:Issue 5(2022)
• Publication Date: 2022-05-03
• Subjects: Case report -- Implantable cardioverter-defibrillator -- Ventricular arrhythmia -- RYTHMIQ; Cardiology -- Periodicals; Cardiology -- Case studies -- Periodicals; Heart -- Diseases -- Periodicals; Heart -- Diseases -- Case studies -- Periodicals; 616.12
• DOI: 10.1093/ehjcr/ytac189
• Languages: English
• ISSNs: 2514-2119

Abstract

Abstract: Background: Minimizing right ventricular (RV) pacing to reduce the progression of heart failure is an established practice. Proprietary algorithms to reduce unnecessary RV pacing have been incorporated into both simple and complex cardiac pacemaker devices, for reducing the possibility of heart failure and arrhythmias. Case summary: We present a case of a 43-year-old male implanted with a dual-chamber primary prevention implantable cardioverter-defibrillator (AUTOGEN EL, Boston Scientific) for sudden cardiac death. At the time of implant, the patient had hypertrophic cardiomyopathy with mild left ventricular (LV) systolic impairment, and sinus rhythm with intact atrioventricular (AV) conduction. The patient developed progression of his disease with symptoms (dyspnoea) and LV impairment. This led to a decision to activate the minimal RV pacing algorithm (RYTHMIQ™). A deterioration in AV conduction caused intrinsic ventricular beats to fall in the atrial blanking period, and subsequent VVI backup pacing resulted in R on T pacing. This induced ventricular arrhythmia. RYTHMIQ™ was subsequently deactivated, and the patient has had no further device-induced arrhythmias. Discussion: Numerous studies have demonstrated the adverse effect of RV pacing on LV function. Minimizing RV pacing is, therefore, encouraged in individuals with intact AV conduction. However, underlying conduction abnormalities must be assessed prior to activating algorithms designed to minimize RV pacing. This case demonstrates the importance of careful intracardiac electrogram interpretation and individual case-based device programming, to avoid device-induced complications.